|
1
|
Koul H, Huh JS, Rove KO, Crompton L, Koul
S, Meacham RB and Kim FJ: Molecular aspects of renal cell
carcinoma: A review. Am J Cancer Res. 1:240–254. 2011.PubMed/NCBI
|
|
2
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe Estimates
for 40 countries in 2012. Eur J Cancer. 49:1374–1403. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Unverzagt S, Moldenhauer I, Nothacker M,
Roßmeißl D, Hadjinicolaou AV, Peinemann F, Greco F and Seliger B:
Immunotherapy for metastatic renal cell carcinoma. Cochrane
Database Syst Rev. 5:Cd0116732017.PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murphy LC, Simon SL, Parkes A, Leygue E,
Dotzlaw H, Snell L, Troup S, Adeyinka A and Watson PH: Altered
expression of estrogen receptor coregulators during human breast
tumorigenesis. Cancer Res. 60:6266–6271. 2000.PubMed/NCBI
|
|
8
|
Liu C, Wu HT, Zhu N, Shi YN, Liu Z, Ao BX,
Liao DF, Zheng XL and Qin L: Steroid receptor RNA activator:
Biologic function and role in disease. Clin Chim Acta. 459:137–146.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lanz RB, Chua SS, Barron N, Soder BM,
DeMayo F and O'Malley BW: Steroid receptor RNA activator stimulates
proliferation as well as apoptosis in vivo. Mol Cell Biol.
23:7163–7176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan Y, Skliris GP, Penner C,
Chooniedass-Kothari S, Cooper C, Nugent Z, Blanchard A, Watson PH,
Myal Y, Murphy LC and Leygue E: Steroid Receptor RNA Activator
Protein (SRAP): A potential new prognostic marker for estrogen
receptor-positive/node-negative/younger breast cancer patients.
Breast Cancer Res. 11:R672009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eoh KJ, Paek J, Kim SW, Kim HJ, Lee HY,
Lee SK and Kim YT: Long non-coding RNA, steroid receptor RNA
activator (SRA), induces tumor proliferation and invasion through
the NOTCH pathway in cervical cancer cell lines. Oncol Rep.
38:3481–3488. 2017.PubMed/NCBI
|
|
12
|
Bennett NC, Rajandram R, Ng KL and Gobe
GC: Evaluation of steroid hormones and their receptors in
development and progression of renal cell carcinoma. J Kidney
Cancer VHL. 1:17–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Langner C, Ratschek M, Rehak P, Schips L
and Zigeuner R: Steroid hormone receptor expression in renal cell
carcinoma: An immunohistochemical analysis of 182 tumors. J Urol.
171:611–614. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Czarnecka AM, Niedzwiedzka M, Porta C and
Szczylik C: Hormone signaling pathways as treatment targets in
renal cell cancer (Review). Int J Oncol. 48:2221–2235. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin L, Zhang X, Zhang L, Feng Y, Weng GX,
Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, et al: Downregulation of
BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal
carcinoma cells. Biochem Biophys Res Commun. 371:531–535. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Qin L, Yang YB, Yang YX, Gong YZ, Li XL,
Li GY, Luo HD, Xie XJ, Zheng XL and Liao DF: Inhibition of smooth
muscle cell proliferation by ezetimibe via the cyclin D1-MAPK
pathway. J Pharmacol Sci. 125:283–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng M, Zeng C, Lu X, He X, Zhang R, Qiu
Q, Zheng G, Jia X, Liu H and He Z: miR-218 suppresses gastric
cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis
in a feedback loop. Cancer Lett. 403:175–185. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Darzynkiewicz Z, Zhao H, Zhang S, Lee MY,
Lee EY and Zhang Z: Initiation and termination of DNA replication
during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1
and the p12 subunit of DNA polymerase delta revealed in individual
cells by cytometry. Oncotarget. 6:11735–11750. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shamanna RA, Hoque M, Pe'ery T and Mathews
MB: Induction of p53, p21 and apoptosis by silencing the NF90/NF45
complex in human papilloma virus-transformed cervical carcinoma
cells. Oncogene. 32:5176–5185. 2013. View Article : Google Scholar
|
|
21
|
Micalizzi DS, Haber DA and Maheswaran S:
Cancer metastasis through the prism of epithelial-to-mesenchymal
transition in circulating tumor cells. Mol Oncol. 11:770–780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu
Y, Yao Y and Li D: The epithelial to mesenchymal transition (EMT)
and cancer stem cells: Implication for treatment resistance in
pancreatic cancer. Mol Cancer. 16:522017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thaper D, Vahid S, Nip KM, Moskalev I,
Shan X, Frees S, Roberts ME, Ketola K, Harder KW, Gregory-Evans C,
et al: Targeting Lyn regulates Snail family shuttling and inhibits
metastasis. . Oncogene. 36:3964–3975. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS,
Tseng LM, Hung SC, Kao SY, Chang CJ and Chiou SH: Bmi-1 regulates
Snail expression and promotes metastasis ability in head and neck
squamous cancer-derived ALDH1 positive cells. J Oncol.
2011:6092592011. View Article : Google Scholar
|
|
25
|
Yuan ZX, Mo J, Zhao G, Shu G, Fu HL and
Zhao W: Targeting strategies for renal cell carcinoma: From renal
cancer cells to renal cancer stem cells. Front Pharmacol.
7:4232016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao W, Gao Z, Duan Y, Yuan W and Ke Y:
Notch signaling plays a crucial role in cancer stem-like cells
maintaining stemness and mediating chemotaxis in renal cell
carcinoma. J Exp Clin Cancer Res. 36:412017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim Y, Yeon M and Jeoung D: DDX53
regulates cancer stem cell-like properties by binding to SOX-2. Mol
Cells. 40:322–330. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hu J, Li J, Yue X, Wang J, Liu J, Sun L
and Kong D: Expression of the cancer stem cell markers ABCG2 and
OCT-4 in right-sided colon cancer predicts recurrence and poor
outcomes. Oncotarget. 8:28463–28470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang MC, Jiao M, Wu T, Jing L, Cui J, Guo
H, Tian T, Ruan ZP, Wei YC, Jiang LL, et al: Polycomb complex
protein BMI-1 promotes invasion and metastasis of pancreatic cancer
stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro,
and in vivo study. Oncotarget. 7:9586–9599. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Senbanjo LT and Chellaiah MA: CD44: A
multifunctional cell surface adhesion receptor is a regulator of
progression and metastasis of cancer cells. Front Cell Dev Biol.
5:182017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su D, Stamatakis L, Singer EA and
Srinivasan R: Renal cell carcinoma: Molecular biology and targeted
therapy. Curr Opin Oncol. 26:321–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lanz RB, McKenna NJ, Onate SA, Albrecht U,
Wong J, Tsai SY, Tsai MJ and O'Malley BW: A steroid receptor
coactivator, SRA, functions as an RNA and is present in an SRC-1
complex. Cell. 97:17–27. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cooper C, Guo J, Yan Y,
Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y and
Leygue E: Increasing the relative expression of endogenous
non-coding Steroid Receptor RNA Activator (SRA) in human breast
cancer cells using modified oligonucleotides. Nucleic Acids Res.
37:4518–4531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin K, Zhan H, Ma J, Xu K, Wu R, Zhou C
and Lin J: Silencing of SRA1 regulates ER expression and attenuates
the growth of stromal cells in ovarian endometriosis. Reprod Sci.
24:836–843. 2017. View Article : Google Scholar
|
|
36
|
Guo W, Jiang H, Li H, Li F, Yu Q, Liu Y,
Jiang W and Zhang M: LncRNA-SRA1 suppresses osteosarcoma cell
proliferation while promoting cell apoptosis. Technol Cancer Res
Treat. 18:15330338198414382019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Son H and Moon A: Epithelial-mesenchymal
transition and cell invasion. Toxicol Res. 26:245–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee JY and Kong G: Roles and epigenetic
regulation of epithelial-mesenchymal transition and its
transcription factors in cancer initiation and progression. Cell
Mol Life Sci. 73:4643–4660. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheng B, Yang G, Jiang R, Cheng Y, Yang H,
Pei L and Qiu X: Cancer stem cell markers predict a poor prognosis
in renal cell carcinoma: A meta-analysis. Oncotarget.
7:65862–65875. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sabnis NG, Miller A, Titus MA and Huss WJ:
The Efflux transporter ABCG2 maintains prostate stem cells. Mol
Cancer Res. 15:128–140. 2017. View Article : Google Scholar :
|
|
42
|
Qin L, Yin YT, Zheng FJ, Peng LX, Yang CF,
Bao YN, Liang YY, Li XJ, Xiang YQ, Sun R, et al: WNT5A promotes
stemness characteristics in nasopharyngeal carcinoma cells leading
to metastasis and tumorigenesis. Oncotarget. 6:10239–10252. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chiu LY, Hsin IL, Yang TY, Sung WW, Chi
JY, Chang JT, Ko JL and Sheu GT: The ERK-ZEB1 pathway mediates
epithelial-mesenchymal transition in pemetrexed resistant lung
cancer cells with suppression by vinca alkaloids. Oncogene.
36:242–253. 2017. View Article : Google Scholar
|
|
44
|
Wang SY, Gao K, Deng DL, Cai JJ, Xiao ZY,
He LQ, Jiao HL, Ye YP, Yang RW, Li TT, et al: TLE4 promotes
colorectal cancer progression through activation of JNK/c-Jun
signaling pathway. Oncotarget. 7:2878–2888. 2016. View Article : Google Scholar :
|
|
45
|
Chuang CH, Greenside PG, Rogers ZN, Brady
JJ, Yang D, Ma RK, Caswell DR, Chiou SH, Winters AF, Grüner BM, et
al: Molecular definition of a metastatic lung cancer state reveals
a targetable CD109-Janus kinase-Stat axis. Nat Med. 23:291–300.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang CJ, Liu C, Wang YX, Zhu N, Hu ZY,
Liao DF and Qin L: Long non-coding RNA-SRA promotes neointimal
hyperplasia and vascular smooth muscle cells proliferation via
MEK-ERK-CREB pathway. Vascul Pharmacol. 116:16–23. 2019. View Article : Google Scholar : PubMed/NCBI
|
